Vigil Neuroscience, Inc. - Common Stock (VIGL)

CUSIP: 92673K108

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 6 signals
Share change
+689,411
SEC-reported price per share
$9.40
Number of holders
46
Value change
+$6,415,535
Number of buys
27
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
46,698,729

Security key

92673K108

Report period

Q2 2023

Institutions

46

Top holders

10

Ownership snapshot

Top reported holders of VIGL - Vigil Neuroscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Vida Ventures GP III, L.L.C.
Disclosed value leader
Atlas Venture Life Scienc...
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $57,142,996 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Atlas Venture Life Science Advisors, LLC has the largest disclosed position value at $57.14M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Atlas Venture Life Science Advisors, LLC's linked filing trail.
Disclosed position value Top 5
Vida Ventures GP III, L.L.C. $18.81M
Northpond Ventures GP, LLC $15.8M
AMGEN INC $12.02M
Cormorant Asset Management, LP $6.04M
Alexandria Venture Investments, LLC $723.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Vida Ventures GP III, L.L.C.
3/4/5
10%+ Owner
—
denominator unverified
$18,809,734
5,015,929 shares
— 11 Jan 2022
Northpond Ventures GP, LLC
3/4/5
10%+ Owner
—
denominator unverified
$15,804,368
4,214,498 shares
— 11 Jan 2022
AMGEN INC
3/4/5
10%+ Owner
—
denominator unverified
$12,023,554
3,206,281 shares
— 11 Jan 2022
Cormorant Asset Management, LP
13F 3/4/5
Company · Former 10% Owner
—
denominator unverified
$6,038,000
616,786 shares
— 31 Mar 2023
Alexandria Venture Investments, LLC
3/4/5
10%+ Owner
—
denominator unverified
$723,649
192,973 shares
— 11 Jan 2022
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
—
denominator unverified
$57,142,996
5,836,874 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
46
Shares
25,748,575
Rows available
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q2 2023 holders
46
Holder diff
45
Investor Q3 2025 Shares Q2 2023 Shares Share Diff Share Chg % Q3 2025 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .